search
Back to results

Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety

Primary Purpose

Illness Anxiety Disorder, Somatic Symptom Disorder

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Self-guided Exposure-based Digital Intervention for Health Anxiety
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Illness Anxiety Disorder focused on measuring Self-guided intervention, Self-help, Digital intervention, Exposure therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 years
  • A principal diagnosis Illness anxiety disorder or somatic symptom disorder (DSM-V)
  • Access to a computer and the internet
  • No serious medical illness
  • Participants on psychotropic medication must have been on a stable dose for the last 4 weeks prior to baseline assessment

Exclusion Criteria:

  • Difficulties to read or write that makes it hard to understand the content of the intervention
  • Currently receiving similar psychological treatment for anxiety
  • High risk of suicide
  • Diagnosed with psychosis disorder or bipolar disorder
  • Ongoing substance dependence
  • Have an urgent need for more intensive psychiatric care

Sites / Locations

  • Centrum för Psykiatriforskning

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Self-guided Exposure-based Digital Intervention for Health Anxiety

Arm Description

Eight weeks of self-guided exposure-based intervention delivered digitally, via the Internet.

Outcomes

Primary Outcome Measures

Change in Health anxiety symptoms
The Short health anxiety inventory - 14 item (SHAI-14). Higher scores indicate greater severity of health anxiety. Scores range from 0 to 42.
Adherence to the treatment: amount of exposures
Will be determined by the amount of exposure exercises reported in the program and in a weekly questionnaire. Acceptable level of adherence will be set to at least 50 % of participants working actively with exposure a majority of the days during a week for 4 weeks or more.
Adherence to the treatment: number of modules
Will be determined by the number of modules completed by the participants.
Adherence to the treatment: types of exposure
Will be determined by the number of different types of exposure exercises performed by participants. At the end of the program, participants will answer yes or no to whether they engaged in each component (type of exposure exercise) of the intervention.
Unintended treatment effects
Participants will be asked to state whether they had experienced any negative or unwanted effects of the treatment. If answering 'Yes', participants will be asked to specify the adverse event in free text. Adverse events will primarily be reported as the total number of reported events.
Satisfaction with treatment
Client Satisfaction Questionnaire (CSQ-8). Scores range from 8-32 with higher scores indicating greater satisfaction. An average Client Satisfaction Questionnaire-8 score of at least 22 will provide support for the acceptability and feasibility of this intervention.

Secondary Outcome Measures

Change in Health anxiety symptoms
The Short health anxiety inventory - 14 item (SHAI-14). Higher scores indicate greater severity of health anxiety. Scores range from 0 to 42.
Change in Health anxiety symptoms
The Short health anxiety inventory - 14 item (SHAI-14). Higher scores indicate greater severity of health anxiety. Scores range from 0 to 42.
Change in depressive symptoms
Patient Health Questionnaire - 9 Item (PHQ-9). Higher total scores indicate greater severity of depression. Scores range from 0 to 27.
Change in depressive symptoms
Patient Health Questionnaire - 9 Item (PHQ-9). Higher total scores indicate greater severity of depression. Scores range from 0 to 27.
Change in depressive symptoms
Patient Health Questionnaire - 9 Item (PHQ-9). Higher total scores indicate greater severity of depression. Scores range from 0 to 27.
Change in diagnostic status
Health Preoccupation Diagnostic Interview (HPDI). HPDI is a structured interview designed to assess Illness anxiety disorder and Somatic symptom disorder according to DSM-V criteria. HPDI will be administered via telephone.
Change in anxiety symptoms
Generalized Anxiety Disorder 7-item scale (GAD-7). Higher total scores indicate greater severity of anxiety symptoms. Scores range from 0 to 21.
Change in anxiety symptoms
Generalized Anxiety Disorder 7-item scale (GAD-7). Higher total scores indicate greater severity of anxiety symptoms. Scores range from 0 to 21.
Change in anxiety symptoms
Generalized Anxiety Disorder 7-item scale (GAD-7). Higher total scores indicate greater severity of anxiety symptoms. Scores range from 0 to 21.
Change in life quality
Brunnsviken Brief Quality of Life Questionnaire (BBQ). A 12-item questionnaire covering six different life domains: leisure time, view on life, creativity, learning, friends and friendship, and view of self. Scores range from 0 to 96, where higher values indicate higher quality of life satisfaction.
Change in life quality
Brunnsviken Brief Quality of Life Questionnaire (BBQ). A 12-item questionnaire covering six different life domains: leisure time, view on life, creativity, learning, friends and friendship, and view of self. Scores range from 0 to 96, where higher values indicate higher quality of life satisfaction.
Credibility/expectancy
The five-item version of Credibility/Expectancy Questionnaire (CEQ). The CEQ ranges from 0 to 10 points per item and 0 to 50 points in total, where a higher score reflects better treatment credibility.
Usability
The System Usability Scale (SUS). The SUS consists of ten items, with a range of 0-4 points per item. The items are summed up and calculated with a formula resulting in a total score between 0 and 100, with a higher score reflecting better system usability.
Experience with the program
A non-validated questionnaire measuring experience working with the program. The scale comprises four questions where participant answer whether the intervention was perceived as likable, easy to understand, whether examples given felt relevant and whether functionality and information contributed to the participant feeling overwhelmed. Answers will be made on a four-point scale ranging from 0 (strongly disagree) to 3 (strongly agree). It will be optional to add a free-text comment to the responses, as well as suggestions of overall improvements.
Post-treatment adherence to exposure exercises
Adherence to the exposure exercises will be determined by an online questionnaire where participant on a four point Likert scale will state to what extent they have worked with exposure: "not at all", "occasionally", "more than half of the days" and "daily".

Full Information

First Posted
June 21, 2022
Last Updated
October 6, 2023
Sponsor
Karolinska Institutet
Collaborators
Region Stockholm
search

1. Study Identification

Unique Protocol Identification Number
NCT05446766
Brief Title
Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety
Official Title
Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
September 6, 2022 (Actual)
Primary Completion Date
March 29, 2023 (Actual)
Study Completion Date
March 29, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
Collaborators
Region Stockholm

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study investigates the feasibility and preliminary efficacy of a self-guided, exposure-based intervention for individuals who suffer from severe health anxiety. The study is a prospective single-group study based at Karolinska Institutet, Stockholm, Sweden, where 20-25 adults with DSM-5 Illness anxiety disorder or Somatic symptom disorder are enrolled in 8 weeks of unguided exposure-based treatment via the Internet. Outcomes include self-reported health anxiety symptoms, credibility and expectancy, adherence to the treatment protocol, client satisfaction, and negative events.
Detailed Description
Background Severe health anxiety (Corresponding to a DSM-5-diagnosis of Illness anxiety disorder or somatic symptom disorder) is a condition associated with high distress, disability and increased health service utilization. Therapist guided Internet delivered cognitive behavioural therapy (ICBT) is efficacious in the treatment of severe health anxiety and has the advantage of requiring less treatment support per patient compared to traditional CBT, thus making the treatment more cost effective. Despite this, the access to ICBT is limited as it requires the active participation of a therapist. Given the relatively high prevalence of individuals experiencing excessive health anxiety, there is need for research on more accessible treatment options. Unguided self-care interventions have the potential to improve access to treatment and increase cost-effectiveness and have a more immediate scalability. Also, unguided interventions have the advantage of being more easily disseminated outside the traditional mental health care systems and thus, have the potential to reach patients with subclinical, yet distressful, health anxiety. Aim The overall aim of this study is to develop a new internet-delivered CBT program based on exposure and response prevention - without therapist support - for patients with severe health anxiety and to examine its feasibility and potential clinical efficacy. Design This is a prospective single-group feasibility study with a pre-post design where a total of 25 participants with Illness anxiety disorder or Somatic symptom disorder (suffering from health anxiety) according to the Diagnostic and statistical manual of mental disorders 5 (DSM-5) are enrolled in an 8 weeks unguided internet based treatment targeting exposure and response prevention. The study will evaluate patient-reported satisfaction, engagement and adherence to treatment protocol, credibility, safety and pre-post changes in health anxiety.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Illness Anxiety Disorder, Somatic Symptom Disorder
Keywords
Self-guided intervention, Self-help, Digital intervention, Exposure therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Psychological intervention, patient-reported outcomes.
Allocation
N/A
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Self-guided Exposure-based Digital Intervention for Health Anxiety
Arm Type
Experimental
Arm Description
Eight weeks of self-guided exposure-based intervention delivered digitally, via the Internet.
Intervention Type
Behavioral
Intervention Name(s)
Self-guided Exposure-based Digital Intervention for Health Anxiety
Intervention Description
An 8-week self-guided internet based CBT intervention which consists of text, exercises, examples and automated support. The format, potentially more accessible compared to traditional ICBT, will be developed with the aim to enhance treatment comprehension and motivation in the participants. The program consists of eight modules (chapters) where the main therapeutic focus is exposure with response prevention. Participant will be interviewed before the program starts, after 8 weeks and 3 months after the program ends. If in need for technical support, participant will be able to ask for assistance via the program and will then be contacted by a clinician via telephone within a couple of days.
Primary Outcome Measure Information:
Title
Change in Health anxiety symptoms
Description
The Short health anxiety inventory - 14 item (SHAI-14). Higher scores indicate greater severity of health anxiety. Scores range from 0 to 42.
Time Frame
pre-treatment assessment to 12 weeks after post-treatment assessment
Title
Adherence to the treatment: amount of exposures
Description
Will be determined by the amount of exposure exercises reported in the program and in a weekly questionnaire. Acceptable level of adherence will be set to at least 50 % of participants working actively with exposure a majority of the days during a week for 4 weeks or more.
Time Frame
Post-treatment assessment (immediately after treatment)
Title
Adherence to the treatment: number of modules
Description
Will be determined by the number of modules completed by the participants.
Time Frame
Post-treatment assessment (immediately after treatment)
Title
Adherence to the treatment: types of exposure
Description
Will be determined by the number of different types of exposure exercises performed by participants. At the end of the program, participants will answer yes or no to whether they engaged in each component (type of exposure exercise) of the intervention.
Time Frame
Post-treatment assessment (immediately after treatment)
Title
Unintended treatment effects
Description
Participants will be asked to state whether they had experienced any negative or unwanted effects of the treatment. If answering 'Yes', participants will be asked to specify the adverse event in free text. Adverse events will primarily be reported as the total number of reported events.
Time Frame
Post-treatment assessment (immediately after treatment)
Title
Satisfaction with treatment
Description
Client Satisfaction Questionnaire (CSQ-8). Scores range from 8-32 with higher scores indicating greater satisfaction. An average Client Satisfaction Questionnaire-8 score of at least 22 will provide support for the acceptability and feasibility of this intervention.
Time Frame
Post-treatment assessment (immediately after treatment)
Secondary Outcome Measure Information:
Title
Change in Health anxiety symptoms
Description
The Short health anxiety inventory - 14 item (SHAI-14). Higher scores indicate greater severity of health anxiety. Scores range from 0 to 42.
Time Frame
pre-treatment assessment to Post-treatment assessment (immediately after treatment)
Title
Change in Health anxiety symptoms
Description
The Short health anxiety inventory - 14 item (SHAI-14). Higher scores indicate greater severity of health anxiety. Scores range from 0 to 42.
Time Frame
pre-treatment assessment to 4 weeks after post-treatment assessment
Title
Change in depressive symptoms
Description
Patient Health Questionnaire - 9 Item (PHQ-9). Higher total scores indicate greater severity of depression. Scores range from 0 to 27.
Time Frame
pre-treatment assessment to12 weeks after post-treatment assessment
Title
Change in depressive symptoms
Description
Patient Health Questionnaire - 9 Item (PHQ-9). Higher total scores indicate greater severity of depression. Scores range from 0 to 27.
Time Frame
pre-treatment assessment to Post-treatment assessment (immediately after treatment)
Title
Change in depressive symptoms
Description
Patient Health Questionnaire - 9 Item (PHQ-9). Higher total scores indicate greater severity of depression. Scores range from 0 to 27.
Time Frame
pre-treatment assessment to 4 weeks after post-treatment assessment
Title
Change in diagnostic status
Description
Health Preoccupation Diagnostic Interview (HPDI). HPDI is a structured interview designed to assess Illness anxiety disorder and Somatic symptom disorder according to DSM-V criteria. HPDI will be administered via telephone.
Time Frame
Change from baseline interview to 12 weeks after post-treatment assessment
Title
Change in anxiety symptoms
Description
Generalized Anxiety Disorder 7-item scale (GAD-7). Higher total scores indicate greater severity of anxiety symptoms. Scores range from 0 to 21.
Time Frame
pre-treatment assessment to 12 weeks after post-treatment assessment
Title
Change in anxiety symptoms
Description
Generalized Anxiety Disorder 7-item scale (GAD-7). Higher total scores indicate greater severity of anxiety symptoms. Scores range from 0 to 21.
Time Frame
pre-treatment assessment to Post-treatment assessment (immediately after treatment)
Title
Change in anxiety symptoms
Description
Generalized Anxiety Disorder 7-item scale (GAD-7). Higher total scores indicate greater severity of anxiety symptoms. Scores range from 0 to 21.
Time Frame
pre-treatment assessment to 4 weeks after post-treatment assessment
Title
Change in life quality
Description
Brunnsviken Brief Quality of Life Questionnaire (BBQ). A 12-item questionnaire covering six different life domains: leisure time, view on life, creativity, learning, friends and friendship, and view of self. Scores range from 0 to 96, where higher values indicate higher quality of life satisfaction.
Time Frame
pre-treatment assessment to 12 weeks after post-treatment assessment
Title
Change in life quality
Description
Brunnsviken Brief Quality of Life Questionnaire (BBQ). A 12-item questionnaire covering six different life domains: leisure time, view on life, creativity, learning, friends and friendship, and view of self. Scores range from 0 to 96, where higher values indicate higher quality of life satisfaction.
Time Frame
pre-treatment assessment to Post-treatment assessment (immediately after treatment)
Title
Credibility/expectancy
Description
The five-item version of Credibility/Expectancy Questionnaire (CEQ). The CEQ ranges from 0 to 10 points per item and 0 to 50 points in total, where a higher score reflects better treatment credibility.
Time Frame
week 3 of treatment
Title
Usability
Description
The System Usability Scale (SUS). The SUS consists of ten items, with a range of 0-4 points per item. The items are summed up and calculated with a formula resulting in a total score between 0 and 100, with a higher score reflecting better system usability.
Time Frame
Post-treatment assessment (immediately after treatment)
Title
Experience with the program
Description
A non-validated questionnaire measuring experience working with the program. The scale comprises four questions where participant answer whether the intervention was perceived as likable, easy to understand, whether examples given felt relevant and whether functionality and information contributed to the participant feeling overwhelmed. Answers will be made on a four-point scale ranging from 0 (strongly disagree) to 3 (strongly agree). It will be optional to add a free-text comment to the responses, as well as suggestions of overall improvements.
Time Frame
Post-treatment assessment (immediately after treatment)
Title
Post-treatment adherence to exposure exercises
Description
Adherence to the exposure exercises will be determined by an online questionnaire where participant on a four point Likert scale will state to what extent they have worked with exposure: "not at all", "occasionally", "more than half of the days" and "daily".
Time Frame
12 weeks after post-treatment assessment
Other Pre-specified Outcome Measures:
Title
Telephone interview
Description
A semi-structured interview concerning the experience of the intervention and format will be conducted via telephone
Time Frame
immediately after treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years A principal diagnosis Illness anxiety disorder or somatic symptom disorder (DSM-V) Access to a computer and the internet No serious medical illness Participants on psychotropic medication must have been on a stable dose for the last 4 weeks prior to baseline assessment Exclusion Criteria: Difficulties to read or write that makes it hard to understand the content of the intervention Currently receiving similar psychological treatment for anxiety High risk of suicide Diagnosed with psychosis disorder or bipolar disorder Ongoing substance dependence Have an urgent need for more intensive psychiatric care
Facility Information:
Facility Name
Centrum för Psykiatriforskning
City
Stockholm
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual data will be available upon reasonable request.

Learn more about this trial

Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety

We'll reach out to this number within 24 hrs